Bayer bids $2.4bn for Norway pharma firm

Bayer bids $2.4bn for Norway pharma firm

German pharmaceutical group Bayer has made a bid for its Norwegian partner and competitor Algeta, specialised in cancer treatments, for 1.8 billion euro ($2.4 billion), the Nordic company said on Tuesday.